NDC 0409-1323-15 - Lidocaine Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1323
- Requested NDC
- 0409-1323-15
- Package NDCs from labels
- 0409-1323-15, 0409-1323-05
- Manufacturer
- Henry Schein, Inc.
- Effective date
- 2026-11-02
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine Hydrochloride - Henry Schein, Inc. | Henry Schein, Inc. | 2026-11-02 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine Hydrochloride - Cardinal Health 107, LLC | Cardinal Health 107, LLC | 2026-10-23 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2026-08-20 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HYDROCHLORIDE - HF Acquisition Co LLC, DBA HealthFirst | HF Acquisition Co LLC, DBA HealthFirst | 2026-07-10 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine Hydrochloride - ProPharma Distribution | ProPharma Distribution | 2025-12-18 | HUMAN PRESCRIPTION DRUG LABEL |
| LIDOCAINE HYDROCHLORIDE - Medical Purchasing Solutions, LLC | Medical Purchasing Solutions, LLC | 2023-05-30 | HUMAN PRESCRIPTION DRUG LABEL |
| Lidocaine Hydrochloride - General Injectables & Vaccines, Inc | General Injectables & Vaccines, Inc | 2022-12-22 | HUMAN PRESCRIPTION DRUG LABEL |
| Sodium Chloride - Aerospace Accessory Service, Inc | Aerospace Accessory Service, Inc | 2021-05-18 | MEDICAL DEVICE |
| LIDOCAINE HYDROCHLORIDE INJECTION, USP | McKesson Corporation dba SKY Packaging | McKesson Corporation dba RX Pak | 2020-01-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1323-05 | Lidocaine Hydrochloride | 10 in 1 CONTAINER | INJECTION, SOLUTION | 10 | 30 | |
| 0409-1323-05 | Lidocaine Hydrochloride | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 30 | |
| 0409-1323-15 | Lidocaine Hydrochloride | 5 mL in 1 SYRINGE, PLASTIC | INJECTION, SOLUTION | 5 | 30 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-1323-05 | ML - Milliliter | 0409-1323 | a117e348-0406-485d-884b-15795bdd24bd | 1 | 2012-07-24 |
| 0409-1323-15 | ML - Milliliter | 0409-1323 | f75f5889-76e8-44e5-b650-d0860874fe0c | 1 | 2020-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Migrafein FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028875c9-4129-ce2c-e063-6294a90a26cc | 2026-11-04 | Warnings | 362O9ITL9D |
| Neo-Lubrina Fuerte | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0288a327-fd4b-1991-e063-6294a90ace50 | 2026-11-04 | Warnings | 362O9ITL9D |
| CAFIZETAMOL FORTE | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 028771d3-a514-f7a5-e063-6394a90ac4f3 | 2026-11-04 | Warnings | 362O9ITL9D |
| CARDIASPIRIN PROTECT | ASPIRIN | OPMX LLC | 03774690-662b-1c30-e063-6294a90a3488 | 2026-11-04 | Warnings | R16CO5Y76E |
| Buscapina | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | OPMX LLC | 048c4b03-1cf4-b724-e063-6294a90a1cad | 2026-11-04 | Warnings | 362O9ITL9D |
| Tenalif Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cd9513-1a42-e990-e063-6294a90a57df | 2026-11-04 | Warnings | 362O9ITL9D |
| Rompe Tos X Children | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cc932d-b412-0710-e063-6394a90a87f6 | 2026-11-04 | Warnings | 362O9ITL9D |
| Rompe Tos X Adults | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05abb2db-d22e-90b5-e063-6294a90ace3f | 2026-11-04 | Warnings | 362O9ITL9D |
| Tenalif Multi Symptom Relief | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | OPMX LLC | 05cd94e7-1808-3bb3-e063-6294a90a4140 | 2026-11-04 | Warnings | 362O9ITL9D |
| COOLA 70 PERCENT PLUS ORGANIC MINERAL BODY SUNSCREEN SPF50 | TITANIUM DIOXIDE, ZINC OXIDE | COOLA, LLC | cb95c712-1680-4040-e053-2995a90af004 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Diphenhydramine HCL | DIPHENHYDRAMINE HCL | PD-Rx Pharmaceuticals, Inc. | c1873a4c-661f-4896-bcc0-f6d3a655de94 | 2026-11-04 | Warnings | TC2D6JAD40 |
| Vertra Ehukai Beige Sunscreen Face Stick Broad Spectrum SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | 303d5d5a-4c7a-1e23-e063-6294a90a0e58 | 2026-11-04 | Warnings | 15FIX9V2JP |
| tabcin NIGHT | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | 0b3ed2bb-88ed-699e-e063-6394a90ac023 | 2026-11-04 | Warnings | 362O9ITL9D |
| Vertra Mick Fanning Signature Foundation Sunscreen Face Stick SPF 35 Coolangatta Beige | TITANIUM DIOXIDE | EAI-JR 286, Inc. | b9ea12e8-6ed9-d805-e053-2a95a90aa107 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra Pearl White Face Stick SPF 50 | PADIMATE O, TITANIUM DIOXIDE | Eai-jr 286, Inc | b69a75e0-8724-35ae-e053-2a95a90a5f34 | 2026-11-04 | Warnings | 15FIX9V2JP |
| Vertra S Dorian Kona Gold Signature Face Stick SPF 38 | TITANIUM DIOXIDE | Eai-jr 286, Inc | b6c316c3-661b-6428-e053-2a95a90a1a6b | 2026-11-04 | Warnings | 15FIX9V2JP |
| Mejoral | ACETAMINOPHEN, CAFFEINE | OPMX LLC | 0bccf571-fcb9-2dd5-e063-6294a90a5f16 | 2026-11-04 | Warnings | 362O9ITL9D |
| RESFRIOL D | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | OPMX LLC | 0e9c96b9-41ac-0faf-e063-6294a90a8ab5 | 2026-11-04 | Warnings | 362O9ITL9D |
| Ampigrin Ultra Forte Night | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | e11e71c3-fe7c-77c7-e053-2995a90a34b2 | 2026-11-04 | Warnings | 362O9ITL9D |
| Nitecin | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE | OPMX LLC | dfb56532-6f72-1e4d-e053-2a95a90a1c05 | 2026-11-04 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.